GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: example 108 [US9655900B2] | TAK-931 | TAK931
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Simurosertib (TAK-931) is an oral Cdc7 (cell division cycle 7-related protein kinase) inhibitor that is being developed by Millennium Pharmaceuticals/Takeda for potential antineoplastic activity in CDC7-overexpressing tumour cells [3]. Cdc7 is a serine/threonine kinase and cell division cycle protein. Simurosertib sensitizes tumour cells to DNA-damaging chemotherapies by functioning to disrupt the cells' ability to recover from DNA damage [2].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
For advanced searching click here to open chemical structure editor
| Similar Ligands  | |||||
| 
 | |||||